Citadel Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History

Citadel Advisors’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-89,900	Closed	-$108K	–	15671
2023 Q1	$108K	Buy	89,900 +52,500	+140%	+$117K	﹤0.01%	11148
2022 Q4	$53.1K	Sell	37,400 -20,500	-35%	-$44K	﹤0.01%	12045
2022 Q3	$141K	Buy	57,900 +12,600	+28%	+$42.1K	﹤0.01%	10783
2022 Q2	$103K	Buy	45,300 +700	+2%	+$2.61K	﹤0.01%	11391
2022 Q1	$300K	Sell	44,600 -56,300	-56%	-$481K	﹤0.01%	10600
2021 Q4	$913K	Sell	100,900 -45,200	-31%	-$420K	﹤0.01%	8180
2021 Q3	$1.48M	Buy	146,100 +26,300	+22%	+$289K	﹤0.01%	7116
2021 Q2	$1.54M	Sell	119,800 -63,700	-35%	-$874K	﹤0.01%	7263
2021 Q1	$2.59M	Sell	183,500 -1,300	-0.7%	-$17.9K	﹤0.01%	5784
2020 Q4	$1.97M	Buy	184,800 +1,100	+0.6%	+$9.99K	﹤0.01%	5384
2020 Q3	$1.4M	Buy	183,700 +25,600	+16%	+$188K	﹤0.01%	5398
2020 Q2	$958K	Sell	158,100 -24,100	-13%	-$119K	﹤0.01%	5909
2020 Q1	$641K	Buy	182,200 +23,300	+15%	+$197K	﹤0.01%	6075
2019 Q4	$1.68M	Sell	158,900 -77,700	-33%	-$690K	﹤0.01%	4701
2019 Q3	$2.65M	Sell	236,600 -75,000	-24%	-$888K	﹤0.01%	4040
2019 Q2	$2.85M	Sell	311,600 -42,000	-12%	-$438K	﹤0.01%	3935
2019 Q1	$3.91M	Buy	353,600 +95,700	+37%	+$669K	﹤0.01%	3336
2018 Q4	$642K	Buy	257,900 +185,700	+257%	+$666K	﹤0.01%	6011
2018 Q3	$325K	Buy	+72,200	New	+$527K	﹤0.01%	7434
2018 Q2	–	Sell	-40,100	Closed	-$618K	–	9433
2018 Q1	$618K	Buy	40,100 +22,100	+123%	+$369K	﹤0.01%	5536
2017 Q4	$294K	Buy	+18,000	New	+$348K	﹤0.01%	6501
2017 Q2	–	Sell	-7,100	Closed	-$218K	–	8247
2017 Q1	$218K	Buy	+7,100	New	+$201K	﹤0.01%	6379
2016 Q2	–	Sell	-13,500	Closed	-$390K	–	7570
2016 Q1	$390K	Buy	13,500 +1,800	+15%	+$47K	﹤0.01%	4748
2015 Q4	$352K	Buy	11,700 +4,400	+60%	+$149K	﹤0.01%	4989
2015 Q3	$217K	Sell	7,300 -25,700	-78%	-$835K	﹤0.01%	6041
2015 Q2	$1.16M	Buy	33,000 +25,700	+352%	+$906K	﹤0.01%	3768
2015 Q1	$259K	Sell	7,300 -15,300	-68%	-$516K	﹤0.01%	5852
2014 Q4	$783K	Buy	22,600 +9,800	+77%	+$346K	﹤0.01%	4085
2014 Q3	$452K	Buy	12,800 +1,500	+13%	+$56.6K	﹤0.01%	4752
2014 Q2	$454K	Sell	11,300 -20,200	-64%	-$775K	﹤0.01%	4523
2014 Q1	$1.26M	Buy	31,500 +16,600	+111%	+$598K	﹤0.01%	3146
2013 Q4	$492K	Buy	14,900 +5,600	+60%	+$175K	﹤0.01%	4041
2013 Q3	$273K	Sell	9,300 -6,100	-40%	-$191K	﹤0.01%	4461
2013 Q2	$519K	Buy	+15,400	New	+$477K	﹤0.01%	3814

Other funds holding DBD

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

BFIM

Beese Fulmer Investment Management Canton, Ohio $1.56B AUM 26.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's DBD Position: Q2 2023 in Review

Citadel Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 180,265 shares — an estimated $216K sold.

Citadel Advisors first reported a position in DBD in Q2 2013 and held it in 37 quarters. The position peaked at $20.6M in Q4 2013. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

Citadel Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
Citadel Advisors sold 180,265 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $216K.
Citadel Advisors first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 37 quarters.
Citadel Advisors's Diebold Nixdorf Incorporated position peaked at $20.6M in Q4 2013.
7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.